Mayne Pharma (ASX:MYX) posts another half-yearly loss, hits seven-year low
- ASX 200 pharmaceutical company Mayne Pharma (MYX) has posted a $17.5 million loss in its latest half-yearly report
- Fierce overseas competition drove revenue, earnings, and profits down for the company compared to the same time the year before
- However, with some severe business restructuring, today's loss is not as heavy as January to June 2019
Mayne Pharma (ASX:MYX) posts another half-yearly loss, hits...
Add to My Watchlist
What is My Watchlist?